Ware Olivia C
CIK: 0001663771
Director
Primary company: Revance Therapeutics, Inc. (RVNC)
Ware Olivia C is a corporate insider at Revance Therapeutics, Inc. (RVNC) filing SEC Form 4 transactions. 29 transactions across 4 companies, totaling $0 in purchases and $1,155,842 in sales. Source: SEC EDGAR.
Companies
Transaction History
Source: SEC EDGAR Form 4 insider transaction filings.
Company | Type | Shares | Price | Value | Shares After | Date | SEC |
|---|---|---|---|---|---|---|---|
| Award | 19,000 | $14.19 | $270K | 19,000 | 6/26/2026 Filed: 6/26/2026 | Filing → | |
| Award | 14,750 | - | - | 14,750 | 6/26/2025 Filed: 6/26/2025 | Filing → | |
Arcellx, Inc. ACLX | Award | 9,174 | - | - | 9,174 | 5/29/2025 Filed: 5/30/2025 | Filing → |
Revance Therapeutics, Inc. RVNC | Disposition | 15,000 | - | - | 0 | 2/6/2025 Filed: 2/6/2025 | Filing → |
Revance Therapeutics, Inc. RVNC | U | 16,675 | $3.65 | $61K | 15,000 | 2/4/2025 Filed: 2/6/2025 | Filing → |
Arcellx, Inc. ACLX | Award | 8,011 | - | - | 8,011 | 5/28/2024 Filed: 6/6/2024 | Filing → |
| Award | 3,700 | - | - | 3,700 | 5/24/2024 Filed: 5/29/2024 | Filing → | |
Revance Therapeutics, Inc. RVNC | Award | 23,458 | - | - | 23,458 | 5/1/2024 Filed: 5/3/2024 | Filing → |
Revance Therapeutics, Inc. RVNC | Award | 15,000 | - | - | 31,675 | 5/1/2024 Filed: 5/3/2024 | Filing → |
Arcellx, Inc. ACLX | Exercise | 9,402 | - | - | 36,806 | 4/16/2024 Filed: 4/18/2024 | Filing → |
Arcellx, Inc. ACLX | Sale | 2,612 | $56.03 | $146K | 0 | 4/16/2024 Filed: 4/18/2024 | Filing → |
Arcellx, Inc. ACLX | Sale | 6,790 | $55.36 | $376K | 2,612 | 4/16/2024 Filed: 4/18/2024 | Filing → |
Arcellx, Inc. ACLX | Exercise | 9,402 | $7.61 | $72K | 9,402 | 4/16/2024 Filed: 4/18/2024 | Filing → |
Arcellx, Inc. ACLX | Exercise | 9,000 | - | - | 46,208 | 3/15/2024 Filed: 3/18/2024 | Filing → |
Arcellx, Inc. ACLX | Sale | 3,337 | $70.99 | $237K | 0 | 3/15/2024 Filed: 3/18/2024 | Filing → |
Arcellx, Inc. ACLX | Sale | 3,763 | $70.36 | $265K | 3,337 | 3/15/2024 Filed: 3/18/2024 | Filing → |
Arcellx, Inc. ACLX | Sale | 1,900 | $69.44 | $132K | 7,100 | 3/15/2024 Filed: 3/18/2024 | Filing → |
Arcellx, Inc. ACLX | Exercise | 9,000 | $7.61 | $68K | 9,000 | 3/15/2024 Filed: 3/18/2024 | Filing → |
Arcellx, Inc. ACLX | Award | 11,459 | $0.00 | $0 | 11,459 | 6/14/2023 Filed: 6/16/2023 | Filing → |
Revance Therapeutics, Inc. RVNC | Award | 5,915 | $0.00 | $0 | 5,915 | 5/3/2023 Filed: 5/5/2023 | Filing → |
Type
Award
Shares
19,000
Price
$14.19
Value
$270K
Type
Award
Shares
14,750
Price
-
Value
-
Arcellx, Inc.
ACLX
Type
Award
Shares
9,174
Price
-
Value
-
Revance Therapeutics, Inc.
RVNC
Type
Disposition
Shares
15,000
Price
-
Value
-
Revance Therapeutics, Inc.
RVNC
Type
U
Shares
16,675
Price
$3.65
Value
$61K
Arcellx, Inc.
ACLX
Type
Award
Shares
8,011
Price
-
Value
-
Type
Award
Shares
3,700
Price
-
Value
-
Revance Therapeutics, Inc.
RVNC
Type
Award
Shares
23,458
Price
-
Value
-
Revance Therapeutics, Inc.
RVNC
Type
Award
Shares
15,000
Price
-
Value
-
Arcellx, Inc.
ACLX
Type
Exercise
Shares
9,402
Price
-
Value
-
Arcellx, Inc.
ACLX
Type
Sale
Shares
2,612
Price
$56.03
Value
$146K
Arcellx, Inc.
ACLX
Type
Sale
Shares
6,790
Price
$55.36
Value
$376K
Arcellx, Inc.
ACLX
Type
Exercise
Shares
9,402
Price
$7.61
Value
$72K
Arcellx, Inc.
ACLX
Type
Exercise
Shares
9,000
Price
-
Value
-
Arcellx, Inc.
ACLX
Type
Sale
Shares
3,337
Price
$70.99
Value
$237K
Arcellx, Inc.
ACLX
Type
Sale
Shares
3,763
Price
$70.36
Value
$265K
Arcellx, Inc.
ACLX
Type
Sale
Shares
1,900
Price
$69.44
Value
$132K
Arcellx, Inc.
ACLX
Type
Exercise
Shares
9,000
Price
$7.61
Value
$68K
Arcellx, Inc.
ACLX
Type
Award
Shares
11,459
Price
$0.00
Value
$0
Revance Therapeutics, Inc.
RVNC
Type
Award
Shares
5,915
Price
$0.00
Value
$0
AI Agent
Try asking...